"With an 80-year history and a team of more than 1,200 healthcare professionals, Miami Jewish Health has been built with a focus on tomorrow, providing access to the latest research trials, offering a comprehensive line of health services, living facilities and programs, and employing an innovative care model centered on empathy."

During the past decade, Miami Jewish Health Systems; Clinical Research conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 2 clinical trials were completed, i.e. on average, 200% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Miami Jewish Health Systems; Clinical Research" are "Alzheimer's Disease" (3 trials). Many other conditions were trialed in "Miami Jewish Health Systems; Clinical Research" in a lesser frequency.

Most popular intervention types in "Miami Jewish Health Systems; Clinical Research" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "Crenezumab" (1 trials), "Gantenerumab" (1 trials), "MABT5102A" (1 trials), "Placebo" (1 trials) and "placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Miami Jewish Health Systems; Clinical Research" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Miami Jewish Health Systems; Clinical Research". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Miami Jewish Health Systems; Clinical Research, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Miami Jewish Health Systems; Clinical Research, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".